Results 51 to 60 of about 16,689 (197)

Myocardial fibrosis in arterial hypertension [PDF]

open access: yes, 2002
It is now accepted that, in addition to left ventricular hypertrophy, hypertensive heart disease is characterized by alterations in myocardial structure, leading to loss of tissue homogeneity and pathological remodelling. It is time to recognize that, in
Diez-Martinez, J. (Javier)   +2 more
core   +1 more source

CMR‐derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 4, April 2026.
This study compared T1 time and ECV in cardiac and thoracic skeletal muscle using CMR in 267 CA patients and 1709 non‐CA controls. Representative T1‐maps (central panel) illustrate regions of interest placed in the cardiac and thoracic skeletal muscle.
Christina Kronberger   +20 more
wiley   +1 more source

Cardiac disease in systemic sclerosis: Integrating pathobiology with clinical management

open access: yesRheumatology &Autoimmunity, Volume 6, Issue 1, Page 16-38, March 2026.
Abstract Systemic sclerosis (SSc) is a complex autoimmune disorder in which cardiovascular involvement remains a major determinant of morbidity and mortality. Cardiac injury in SSc results from the interplay of microvascular dysfunction, immune‐mediated inflammation, and progressive interstitial and replacement fibrosis, leading to myocardial disease ...
Henry Sutanto, Betty Rachma, Yuliasih
wiley   +1 more source

Diagnostic value of galectin-3 in heart transplant recipients with myocardial complications

open access: yesВестник трансплантологии и искусственных органов, 2020
Objective: to determine the diagnostic value of galectin-3 in transplant recipients with myocardial fibrosis and acute heart transplant rejection, verified by endomyocardial biopsy. Materials and methods.
O. P. Shevchenko   +6 more
doaj   +1 more source

Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy. [PDF]

open access: yesPLoS ONE, 2016
Risk stratification of patients with non-ischemic dilated cardiomyopathy remains a matter of debate in the era of device implantation.We investigated associations between histopathological findings, contrast-enhanced cardiac MRI and the inducibility of ...
Karin A L Mueller   +11 more
doaj   +1 more source

Ischemic Stroke in Hypereosinophilic Syndrome: A Clinicopathologic Study of Two Cases

open access: yesNeuropathology, Volume 46, Issue 1, February 2026.
ABSTRACT Ischemic stroke is a rare complication of hypereosinophilic syndrome (HES). Manifestations of stroke in HES have been described in the radiologic literature; however the pathologic characterization of central nervous system (CNS) involvement in HES is limited.
Karina C. Martin   +3 more
wiley   +1 more source

Right Ventricular Endomyocardial Fibrosis Presenting With Ventricular Tachycardia And Apical Thrombus - An Interesting Presentation

open access: yesIndian Pacing and Electrophysiology Journal, 2009
Endomyocardial fibrosis is a progressive disease of unknown origin affecting children and young adults. It involves inflow portion of right and/or left ventricle and apex. It may be associated with thrombus.
Amitesh Aggarwal   +4 more
doaj  

Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure

open access: yesFrontiers in Physiology, 2017
Myocardial fibrosis is an important part of cardiac remodeling that leads to heart failure and death. Myocardial fibrosis results from increased myofibroblast activity and excessive extracellular matrix deposition.
Tong Liu   +9 more
doaj   +1 more source

Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy [PDF]

open access: yes, 2015
Background: Inflammatory dilated cardiomyopathy (iDCM) is a common debilitating disease with poor prognosis that often leads to heart failure and may require heart transplantation.
Bironaite, Daiva   +10 more
core   +1 more source

Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease

open access: yesVeterinary Medicine and Science, Volume 12, Issue 1, January 2026.
Reduces cardiac remodelling and apoptosis in dogs with MMVD stage B2: Long‐term treatment with ivabradine in dogs with asymptomatic myxomatous mitral valve disease (MMVD) stage B2 reduced heart rate without impairing cardiac function. ABSTRACT Background Ivabradine, a specific funny channel blocker, has shown cardiovascular benefits in humans and ...
Prapawadee Pirintr   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy